Please check your internet connection and try again.
# Mylot%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520at
## Overview
Mylot%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520at is a brand name for a topical medication containing lidocaine. Lidocaine is a local anesthetic of the amide type.
## Primary Indications
Mylot%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520at is indicated for the temporary relief of pain and itching associated with minor cuts, scrapes, burns, insect bites, and sunburn. It may also be used for pain associated with hemorrhoids and other anorectal conditions, depending on the specific formulation.
## Adult Dosing
For topical application to the skin for pain and itching: Apply a thin layer to the affected area as needed, typically every 4 to 8 hours. Do not exceed a total daily dose of 1000 mg of lidocaine from all sources.
For anorectal use (if applicable to the specific Mylot%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520at product): Follow product-specific instructions, often involving application to the affected area up to 4 times daily.
## Pediatric Dosing
Dosing in pediatric patients (under 12 years) should be based on local protocols and physician discretion. Generally, it is recommended to use the lowest effective dose in the youngest patients and to avoid application to large surface areas or areas with broken skin due to increased risk of systemic absorption. Consult specific product labeling for age restrictions.
## Dose Adjustments
No specific dose adjustments are generally required for adults with hepatic or renal impairment when used topically at recommended doses, as systemic absorption is typically minimal. However, caution is advised with extensive application or in patients with severely compromised hepatic function.
## Contraindications
Hypersensitivity to lidocaine or other amide-type local anesthetics.
## Adverse Effects
Common adverse effects include localized skin irritation, redness, or burning at the application site. Systemic effects are rare with appropriate topical use but can occur with excessive application, prolonged use, or application to large denuded areas, and may include central nervous system effects (drowsiness, dizziness, confusion, seizures) and cardiovascular effects (bradycardia, hypotension, arrhythmias).
## Key Drug Interactions
* **Antiarrhythmics (e.g., amiodarone, procainamide):** Increased risk of additive cardiac effects.
* **Beta-blockers:** May slow lidocaine metabolism, increasing lidocaine plasma levels.
* **CYP1A2 inhibitors (e.g., cimetidine, fluvoxamine):** May slow lidocaine metabolism.
## Monitoring
Monitor for signs of local irritation or allergic reaction. In cases of extensive application, prolonged use, or suspected systemic absorption, monitor for central nervous system and cardiovascular adverse effects.
## Clinical Pearls
* Avoid contact with eyes.
* Do not apply to broken or severely damaged skin without consulting a healthcare provider.
* Be aware of the total daily lidocaine dose from all sources to prevent systemic toxicity.
* Effectiveness and safety in pediatric patients can vary; use with caution and at the lowest effective dose.
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and product labeling for Mylot%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520at and relevant clinical guidelines before making any treatment decisions.**
